Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer

Figure 4

Growth inhibition of xenograft tumours. Subcutaneous (A) and intrapancreatic (B) xenograft tumour growth of T3M4 cells in nude mice treated with PBS (sham), belinostat, gemcitabine or belinostat + gemcitabine. The mean of the tumour volume was calculated from measurable tumours at each time point. In summary, tumours in the treatment groups were smaller compared to sham. The differences between the treatment groups were not significant. Data are presented as mean ± SEM. * p < 0.05

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us